HIV-1 Capsid Assembly Inhibitor (CAI) Peptide: Structural Preferences and Delivery into Human Embryonic Lung Cells and Lymphocytes

The Human immunodeficiency virus 1 derived capsid assembly inhibitor peptide (HIV-1 CAI-peptide) is a promising lead candidate for anti-HIV drug development. Its drawback, however, is that it cannot permeate cells directly. Here we report the transport of the pharmacologically active CAI-peptide int...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Klaus, Frank, Martin, Pipkorn, Rüdiger, Reed, Jennifer, Spring, Herbert, Debus, Jürgen, Didinger, Bernd, von der Lieth, Claus-Wilhelm, Wiessler, Manfred, Waldeck, Waldemar
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2008
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500149/
https://www.ncbi.nlm.nih.gov/pubmed/18695744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500149/
https://www.ncbi.nlm.nih.gov/pubmed/18695744

Ejemplares similares